"From Harm to Charm": UNC Wilmington Biotechnology Program, MARBIONC, Receives Second Patent
Thursday, October 2, 2008 - 20:28
in Health & Medicine
MARBIONC, a biotechnology development program at the University of North Carolina Wilmington Center for Marine Science, has received a second patent for marine-derived substances that may be beneficial in the treatment of cystic fibrosis and asthma.